Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ambrx

Request full access

A biopharmaceutical company with a mission to deliver breakthrough protein therapeutics

San Diego, United StatesFounded 2003Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2021

Ambrx in the San Diego ecosystem

Live from Dealroom

The Ambrx office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

22 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • M Ventures

Series B and later21 investors entered at this stage

  • Tavistock Group
  • University of California
  • Berkeley
  • BlackRock
  • Sinopharm Group
  • Adage Capital
  • Apricot Capital
  • Roche Venture Fund
  • Versant Ventures
  • China Everbright Limited
  • CMEA Capital
  • Cormorant Asset Management
  • 5AM Ventures
  • Northeast Securities
  • Maverick Capital
  • Fidelity Investments
  • Invus
  • Apposite Capital
  • Aravis Ventures
  • Suvretta Capital Management
  • Maverick Ventures Israel
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$127M

43 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Ambrx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.